DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “US Macular Edema Market and Competitive Landscape Highlights – 2016” drug pipelines to their offering. US Macular Edema Market and Competitive Landscape Highlights – 2016,…
Rayner purchases Moorfields Pharmaceuticals
Moorfields Pharmaceuticals has been purchased from Moorfields Eye Hospital NHS Foundation Trust by Rayner.Rayner is planning to launch a specialist ophthalmic pharmaceuticals division, expanding its European presence, and bought Moorfields for an undis…
Practice pearls for thriving in the changing health care scenario
At Kiawah Eye, Alan Kozarsky, MD, relates his experience regarding how to prepare for the changing health care scenario; for example, practices should be prepared for reimbursements to take into account not only quantity but also quality of care.
Virtual Reality Initiative aims to provide emotional benefit to young cancer patients
The University of Southern California Norris Comprehensive Cancer Center has partnered with Springbok Cares to provide a unique Virtual Reality (VR) initiative for patients in the Adolescent and Young Adult Cancer program at USC.
Publication Exclusive: Extra steps should be taken to make surgery patients comfortable
While most ophthalmic surgeons consider cataract surgery a relatively painless experience for the patient, controlled studies confirm that about one in three patients experience moderate to severe pain during the procedure. In addition, the fact that s…
Regeneron’s Eylea Combination Therapy Fails Mid-Stage Study
Regeneron Pharmaceuticals Inc said a combination therapy containing its flagship eye drug, Eylea (aflibercept), was inferior to Eylea alone in a mid-stage trial involving patients with wet age-related macular degeneration (AMD), a leading cause of blin…